ClearBridge Global Growth Fund

This fund invests in growth companies where the portfolio managers have a differentiated view on the duration and/or magnitude of growth across global developed and emerging markets.

Key Portfolio Information

As at 30 April 2024 (returns in AUD after fees)

Performance 1 Month 3 Months 1 Year 3 Years 5 Years Inception4
ClearBridge Global Growth Fund (AUD)123 -4.7% 2.9% - - - 8.8%
MSCI AC World (Net) (AUD) Index -2.8% 5.9% - - - 9.6%
Excess Returns -1.9% -3.0% - - - -0.8%

As at 30 April 2024

  • ClearBridge Global Growth Fund
  • MSCI AC World (Net) (AUD) Index

As at 30 April 2024

Top 10 Positions Region Sector Portfolio
Weight %
Benchmark
Weight %
Microsoft Corporation North America Information Technology 4.7% 3.9%
Amazon.com, Inc. North America Consumer Discretionary 3.8% 2.3%
Eli Lilly and Company North America Health Care 3.4% 0.9%
Alphabet Inc. Class A North America Communication Services 3.3% 2.6%
Apple Inc. North America Information Technology 3.3% 3.6%
NVIDIA Corporation North America Information Technology 3.1% 3.1%
Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR Emerging Markets Information Technology 2.4% 0.0%
Meta Platforms Inc Class A North America Communication Services 2.3% 1.4%
Marvell Technology, Inc. North America Information Technology 2.3% 0.1%
Union Pacific North America Industrials 2.1% 0.2%
Fund Details April 2024
APIR Code SSB3170AU
Portfolio Weighted Average April 2024
Avg Market Capitalisation 925.2bn (AUD)
PE Ratio (FY1 Est) 25.0
Price/Book 6.3
Est 3-5 Yr EPS Growth 15.7%
ROE 21.8%
Dividend Yield 0.9%

Investment Objective: To generate long term capital appreciation by investing in global companies which are undervalued when compared to the Portfolio Manager's assessment of their intrinsic value and to outperform the benchmark, being the MSCI All Country World – NR Index.

For detailed information regarding our fees and transaction costs, please refer to the relevant Product Disclosure Statement here.

Unit Prices & Distributions

Date CCY Nav Entry Exit
27/05/202427/5/24 AUD 1.1190 1.1198 1.1182
24/05/202424/5/24 AUD 1.1234 1.1242 1.1226
23/05/202423/5/24 AUD 1.1192 1.1200 1.1184

Product Commentary

Equity Insights Portfolio Insights
Global Growth Strategy April Commentary

Global Growth Strategy April Commentary

Recent results validate the need for investors seeking global exposure to include growth equities in their portfolio. The U.S. continues to show economic and earnings resilience as a soft landing comes into view.

More...
Equity Insights
International Companies Drive Diabesity Innovation

International Companies Drive Diabesity Innovation

Diabetes and obesity (“diabesity”) have rapidly become the largest opportunity in health care, with an estimated total long-term addressable market of $100 billion in the U.S. alone. Research & development outside the U.S. has provided actionable insights into the blockbuster market for diabesity treatments.

More...

Investment Committee

The ClearBridge Global Growth Fund is managed by an experienced investment committee comprising of the following members:

Elisa Mazen, ClearBridge Investments, LLC
Elisa Mazen, ClearBridge Investments, LLC
Michael Testorf, CFA, ClearBridge Investments, LLC
Michael Testorf, CFA, ClearBridge Investments, LLC
Pawel Wroblewski, CFA, ClearBridge Investments, LLC
Pawel Wroblewski, CFA, ClearBridge Investments, LLC

Important Information for Investors

Franklin Templeton Australia Limited (AFSL No. 240827) ("Franklin Templeton"), as Responsible Entity, is the issuer of the ClearBridge Global Growth Fund (ARSN 671 563 607). The information contained on this website is directed to wholesale investors and financial advisers only.

Contact us to find out how we can help investors allocate global equities into their broader portfolio or to learn more about our other investment capabilities.

Contact us

Need more information?

Disclaimer

1. Sources: Internal calculations for the ClearBridge Global Growth Fund. Income and growth data sourced from JPM. All index data sourced from FactSet. Results over one year annualised.
2. Fund performance is net of fees, assuming all distributions are reinvested and before tax.
3. All values in AUD and net of withholding taxes for benchmarks, if applicable. Non-AUD values converted into AUD using FactSet Forex data.
4. Performance inception date for the ClearBridge Global Growth Fund is 14/12/2023.

Past performance is not indicative of future performance. 

While the information contained on this website has been prepared with all reasonable care, ClearBridge Investments* accepts no responsibility or liability for any errors, omissions or misstatements however caused. Any views expressed on this website are given as of the date of publication and such views are subject to change at any time. This information is not personal advice. It has been prepared without taking account of individual objectives, financial situation or needs. Where an investment product is mentioned, potential investors should seek independent advice as to the suitability of the product to their investment needs. Reference to shares in a particular company, is not a recommendation to buy, sell or hold that stock. Investors should be aware that past performance is not indicative of future performance.

This website may contain forecasts, including in regard to targets, expected returns, PE ratios and dividend yields. Any such statements are based upon research undertaken by the investment teams. This research incorporates our reasonable assumptions and beliefs concerning future developments and their potential effect but are subject to risks and uncertainties that may be beyond our control. Returns can be volatile, reflecting rises and falls in the value of underlying investments. Accordingly, we do not provide any assurance or guarantee that future developments will be aligned with our expectations, and actual results may differ materially from those expected or anticipated at the time of writing.

Franklin Templeton Australia Limited (AFSL No. 240827) (“Franklin Templeton”) is a part of Franklin Resources, Inc. and the Responsible Entity for certain ClearBridge managed Funds (the “Funds”). Applications to invest can only be made on the application form accompanying the most recent Fund Product Disclosure Statement (“PDS”) which is available on this website. Potential investors should read the relevant PDSs and the Additional Information Booklet (“AIB”) before making an investment decision. The PDSs and AIB can be obtained on this website or by contacting us: by telephone on (02) 9397 7351, by writing to ClearBridge Investments Limited (ABN 84 119 339 052; AFSL No. 307727), Level 13, 35 Clarence Street, Sydney, NSW 2000 or by email at [email protected]. Franklin Templeton can be contacted by writing to Franklin Templeton, Level 47, 120 Collins Street, Melbourne, VIC 3000 or by telephone on 1800 673 776.  In accordance with the Design and Distribution Obligations and Product Interventions Powers requirements the Responsible Entity maintains Target Market Determinations (“TMD”) for each of the Funds. All documents can be found on this website on the Forms & Downloads page, by contacting Client Service on (02) 9397 7351 or by email at [email protected]

Franklin Templeton does not guarantee any rate of return or the return of capital invested. Investments are subject to risks, including, but not limited to, possible delays in payments and loss of income or capital invested.

ClearBridge Investments is wholly, indirectly owned by Franklin Resources, Inc.

*ClearBridge Investments consists of ClearBridge Investments, LLC. (“CBI”) and its affiliated managers whose businesses have been operationally integrated with CBI’s, including ClearBridge Investments Limited and its subsidiary in Australia, and a part of Franklin Templeton Investments Corp. doing business as ClearBridge Investments in Canada.